Discordance Between HIV Risk Perception, Sexual Behavior, and Pre-exposure Prophylaxis Adherence Among Young Sexual and Gender Minorities in the United States
- PMID: 38583158
- PMCID: PMC11102322
- DOI: 10.1016/j.jadohealth.2024.02.028
Discordance Between HIV Risk Perception, Sexual Behavior, and Pre-exposure Prophylaxis Adherence Among Young Sexual and Gender Minorities in the United States
Abstract
Purpose: In the United States, youth experience suboptimal HIV pre-exposure prophylaxis (PrEP) adherence. One common idea posits that this is due to their developing decision-making skills. However, quantitative evidence of this assumption is limited. We therefore examined whether individual decision-making factors, such as HIV risk perception and sexual behavior, predicted PrEP adherence in a national trial of young sexual and gender minorities (YSGMs).
Methods: In 2019-2021, the Adolescent Medicine Trials Network for HIV Interventions 142 study enrolled 225 PrEP users (ages 16-24) throughout the country. Regression models estimated the associations between HIV risk perception (using a modified Perceived HIV Risk Scale), sexual behavior (condomless anal sex in ≤ 3 months), and self-reported oral PrEP adherence (≥4 pills in the past week) at the same time point (baseline) and longitudinally (3 months).
Results: Baseline risk perception (risk ratio [RR]: 0.92, 95% confidence interval [CI]: 0.82, 1.04) and condomless anal sex (RR: 1.10, 95% CI: 0.97, 1.25) were not associated with PrEP adherence at the same time point and did not predict 3-month adherence (RR: 0.97, 95% CI: 0.85, 1.11; RR: 1.05, 95% CI: 0.93, 1.19, respectively). Baseline risk perception was not associated with condomless anal sex at either time point (baseline RR: 1.16, 95% CI: 0.94, 1.43; 3-month RR: 1.07, 95% CI: 0.90, 1.28).
Discussion: In this national trial of YSGM, HIV risk perception and condomless anal sex did not predict PrEP adherence. Targeting individual-level perceptions and behaviors will likely insufficiently address youth's suboptimal PrEP use. Future research should identify YSGM-specific adherence drivers and train providers to recognize such motivations.
Keywords: Adherence; HIV pre-exposure prophylaxis; HIV prevention; Risk perception; Young sexual and gender minorities.
Copyright © 2024 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Similar articles
-
Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants.Int J Drug Policy. 2019 Dec;74:246-254. doi: 10.1016/j.drugpo.2019.10.007. Epub 2019 Nov 15. Int J Drug Policy. 2019. PMID: 31739177 Free PMC article. Clinical Trial.
-
Medical chart-reported alcohol consumption, substance use, and mental health issues in association with HIV pre-exposure prophylaxis (PrEP) nonadherence among gay, bisexual, and other men-who-have-sex-with-men.BMC Public Health. 2024 Dec 18;24(1):3487. doi: 10.1186/s12889-024-20934-7. BMC Public Health. 2024. PMID: 39696067 Free PMC article.
-
Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.AIDS Behav. 2016 Dec;20(Suppl 3):357-364. doi: 10.1007/s10461-016-1536-1. AIDS Behav. 2016. PMID: 27631366
-
Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis.Clin Infect Dis. 2018 Aug 16;67(5):676-686. doi: 10.1093/cid/ciy182. Clin Infect Dis. 2018. PMID: 29509889
-
The Association between Social Support and Pre-Exposure Prophylaxis use among Sexual Minority Men in the United States: A Scoping Literature Review.AIDS Behav. 2024 Nov;28(11):3559-3573. doi: 10.1007/s10461-024-04446-4. Epub 2024 Jul 23. AIDS Behav. 2024. PMID: 39039399 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Prevent HIV: Ending the HIV Epidemic. Available at: https://www.cdc.gov/endhiv/prevent.html. AccessedMarch 29, 2023.
-
- Centers for Disease Control and Prevention. Ending the HIV Epidemic in the U.S. (EHE). Available at: https://www.cdc.gov/endhiv/index.html. AccessedMarch 29, 2023.
-
- Spinner CD, Boesecke C, Zink A, et al. HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans. Infection 2016;44:151–8. - PubMed
-
- Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2020. HIV Surveillance Supplemental Report; 2022.
-
- Sullivan PS, Johnson AS, Pembleton ES, et al. Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses. The Lancet 2021;397:1095–106. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous